Results 211 to 220 of about 1,864,473 (295)

Effectiveness of Mobile Application‐Based Multimodal Behavioral Interventions on Weight Loss in Obesity: A Systematic Review and Meta‐Analysis

open access: yesObesity Reviews, EarlyView.
ABSTRACT Background Healthcare systems face increasing demands in chronic disease management such as obesity. Mobile applications offer scalable tools for weight management, ranging from simple trackers to prescribable digital therapeutics. Objective This review evaluates the effectiveness of fully remote, app‐based interventions using a multimodal ...
Emma Bodner   +4 more
wiley   +1 more source

Kwashiorkor Mimicking Portal Hypertensive Ascites After Bariatric Surgery. [PDF]

open access: yesACG Case Rep J
Dixon W, Bromfield B, Redston M, Sack J.
europepmc   +1 more source

Toward “Obesityomics”: Domain‐Specific Omics in Precision Obesity Medicine with a Brief AI Perspective

open access: yesObesity Reviews, EarlyView.
ABSTRACT Background Obesity's global rise has outpaced the effectiveness of “one‐size‐fits‐all” prevention and treatment strategies. The promise of precision medicine lies in addressing the etiological and biological diversity of obesity and transforming it into actionable endotypes.
Nadia Abu Samra   +13 more
wiley   +1 more source

The Lived Experience of Children and Adults with Overweight or Obesity Engaging in Weight Management Treatments: An Umbrella Scoping Review with Narrative Synthesis

open access: yesObesity Reviews, EarlyView.
ABSTRACT Introduction Understanding the lived experience of people with overweight or obesity is essential to ensure that interventions are free from weight stigma, avoid adverse consequences including eating disorder pathology, increase engagement, and promote culturally sensitive approaches to care. We aimed to synthesize published review evidence of
Cecelia MacFarling Meure   +14 more
wiley   +1 more source

The Changing Landscape of Metabolic and Bariatric Surgery: Aligning Access With the Clinical Obesity Framework

open access: yesObesity Reviews, EarlyView.
ABSTRACT Metabolic and bariatric surgery (MBS) is the most effective treatment for severe obesity, yet it remains profoundly underutilized. Patients seeking MBS face pretreatment requirements, including mandatory psychological evaluation, documented failed diet attempts, and months of lifestyle interventions that are substantially more extensive than ...
Francesco Saverio Papadia   +3 more
wiley   +1 more source

Menstrual and Reproductive Function Before and After Metabolic Bariatric Surgery. [PDF]

open access: yesObes Surg
Whyte M   +5 more
europepmc   +1 more source

AI‐Driven Personalized Recommendations and Real‐Time Monitoring for the Prevention and Management of Obesity: Clinical Trial Protocol for the Multicentre BETTER4All Personalized Intervention

open access: yesObesity Reviews, EarlyView.
ABSTRACT Background Obesity arises from complex interactions among genetic, biological, behavioral, and environmental factors. Traditional “one‐size‐fits‐all” interventions often yield modest, short‐term outcomes, failing to account inter‐individual variability.
Eva Karaglani   +34 more
wiley   +1 more source

Influence of GLP‐1‐Based Pharmacotherapies on Eating Behavior, Appetite, and Energy Intake in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis

open access: yesObesity Reviews, EarlyView.
ABSTRACT Introduction Although GLP‐1‐based pharmacotherapies achieve clinically significant weight loss, their influence on eating behavior is unknown. Methods This systematic review examined the effects of GLP‐1‐based pharmacotherapies on eating behavior, appetite, and energy intake in adults (≥ 18 years) with overweight or obesity (BMI ≥ 25 kg/m2 ...
Clarissa Dakin   +2 more
wiley   +1 more source

Preconception Weight Change and Pregnancy Outcomes After Bariatric Surgery. [PDF]

open access: yesJ Clin Med
Guthrie T   +6 more
europepmc   +1 more source

GLP‐1 Receptor Agonists and Cancer Risk in Obesity Treatment

open access: yesObesity Reviews, EarlyView.
ABSTRACT Obesity is a well‐established risk factor for numerous cancers, with body habitus, especially central adiposity, contributing to increased cancer incidence and worse prognosis. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), initially developed to treat Type 2 diabetes, have rapidly gained prominence as powerful anti‐obesity agents due ...
Lorne J. Hofseth   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy